Information sur le cancer / Types de cancer / Leucémie myéloïde chronique (LMC) / Traitement / Récidivante ou réfractaire

American Cancer Society. (2013, September 23). Leukemia - Chronic Myeloid (Myelogenous). Atlanta, GA. Retrieved 09/30/2014. Extrait de: http://www.cancer.org/acs/groups/cid/documents/webcontent/003112-pdf.pdf.

Druker BJ, Lee SJ. Chronic myelogenous leukemia. DeVita VT Jr, Lawrence TS, & Rosenberg SA. (2014, May 29). Cancer: Principles & Practice of Oncology. (9th Édition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 133: pp. 1962-1972.

Health Canada. (2014, May 14). Drugs and Health Products: Summary Basis of Decision (SBD): Bosulif. Ottawa, ON: Health Canada. Extrait de: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/drug-med/sbd_smd_2014_bosulif_152211-eng.php.

Health Canada. (2011, June 30). Drugs and Health Products: Sprycel (dasatinib). Ottawa, ON: Health Canada. Extrait de: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/notices-avis/conditions/sprycel_dhcpl_lapds_104993-eng.php.

Health Canada. (2015, April 2). Drugs and Health Products: Approval of Iclusig with conditions. Ottawa, ON: Health Canada. Extrait de: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/notices-avis/conditions/iclusig_dhcpl_lapds_165121-eng.php.

O'Brien SG, Goldman JM. Diagnosis and treatment of chronic myeloid leukemia. Wiernik PH, Goldman JM, Dutcher JP & Kyle RA (eds.). (2013). Neoplastic Diseases of the Blood. (5th Édition). Springer. 5: pp. 45-62.